ロード中...
Durable Response to Brentuximab Vedotin-Based Chemotherapy in Refractory Hodgkin Lymphoma with Central Nervous System (CNS) Involvement
Patient: Female, 29-year-old Final Diagnosis: Refractory Hodgkin lymphoma with CNS involvement Symptoms: Blurred vision Medication: — Clinical Procedure: — Specialty: Hematology OBJECTIVE: Rare disease BACKGROUND: CNS involvement in Hodgkin lymphoma is rare. Despite various treatment options, median...
保存先:
| 出版年: | Am J Case Rep |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Scientific Literature, Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7083218/ https://ncbi.nlm.nih.gov/pubmed/32170052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AJCR.921657 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|